HUP0401925A3
(en )
2007-05-29
A2b adenosine receptor antagonists
IL175759A0
(en )
2006-09-05
A2b adenosine receptor antagonists
AU6808901A
(en )
2001-12-11
Adenosine a2a receptor antagonists
IL161572A0
(en )
2004-09-27
Adenosine a2a receptor antagonists
HK1063780A1
(en )
2005-01-14
Adenosine a2a receptor antagonists
IL158214A0
(en )
2004-05-12
8-heteroaryl xanthine adenosine a2b receptor antagonists
IL174771A0
(en )
2006-08-20
Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
GB0112617D0
(en )
2001-07-18
Antiviral nucleoside derivatives
PL377632A1
(pl )
2006-02-06
Przeciwwirusowe pochodne nukleozydów
AU5316000A
(en )
2000-12-18
Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
IL160878A0
(en )
2004-08-31
Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
HUP0401437A3
(en )
2007-05-29
Adenosine a3 receptor agonists
HK1064097A1
(en )
2005-01-21
Bicyclic Ä1,2,4Ü -triazole adenosine a2a receptor antagonists
HRP20050540A2
(en )
2005-08-31
Imidazoquinoline derivatives as adenosine a3 receptor ligands
PL373953A1
(en )
2005-09-19
7-amino-benzothiazole derivatives as adenosine receptor ligands
SI1622912T1
(sl )
2009-10-31
2-alkinil- in 2-alkenil-pirazolo-(4,3-E)-1,2,4-triazolo-(1,5-C)-pirimidin adenozinski A2a receptorski antagonisti
IL156046A0
(en )
2003-12-23
Condensed purine derivatives as a1 adenosine receptor antagonists
AU2003231805A8
(en )
2004-02-09
Purine derivatives as liver x receptor agonists
IL148366A0
(en )
2002-09-12
Selective antagonists of a2b adenosine receptors
AU2003301589A8
(en )
2004-05-13
Purine nucleosides
IL162444A0
(en )
2005-11-20
Triazolo-quinolin derivatives useful as adenosine receptor ligands
PL370565A1
(en )
2005-05-30
5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
EP1636230A4
(en )
2010-06-16
ADENOSINE A1 RECEPTOR ANTAGONISTS
SI1401837T1
(sl )
2006-02-28
Purinski derivati kot antagonisti adenozinskega receptorja A2B
AU2002320199A1
(en )
2003-03-03
Purine derivatives as a2b adenosine receptor antagonists